Drug Profile
Estradiol vaginal - Pfizer
Alternative Names: EstringLatest Information Update: 28 Oct 2021
Price :
$50
*
At a glance
- Originator Pfizer
- Developer Endo International; Pfizer
- Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Genitourinary disorders